Search Results

Your search for Craig E. Pollack, MD,Craig E. Pollack, MD matches 3 pages

Showing 1 - 3

By ASCO / June 10, 2016

2016 ASCO Annual Meeting Planning Committees

The ASCO Annual Meeting highlights the latest research and treatment advances in oncology, with nearly 30,000 oncology professionals attending each year. ASCO wishes to acknowledge the volunteers on this year’s Cancer Education and Scientific Program Committees and thank them for their time and...

survivorship

breast cancer

By Craig E. Pollack, MD / 2016 Cancer Survivorship Symposium

Craig E. Pollack, MD, on Low-Income Breast Cancer Survivors: Clinical Trial Results

Craig E. Pollack, MD, of Johns Hopkins University, discusses a study of survivorship care plans for this special population (Abstract 1).

By ASCO / June 25, 2015

2015 ASCO Annual Meeting Planning Committees

The ASCO Annual Meeting highlights the latest research and treatment advances in oncology, with more than 28,000 oncology professionals attending each year. ASCO wishes to acknowledge the volunteers on this year’s Cancer Education and Scientific Program Committees, and thank them for their time and ...

Nov

Today In Oncology

Search Results

Your search for Craig E. Pollack, MD,Craig E. Pollack, MD matches 3 pages

2016 ASCO Annual Meeting Planning Committees

Craig E. Pollack, MD, on Low-Income Breast Cancer Survivors: Clinical Trial Results

2015 ASCO Annual Meeting Planning Committees

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer

FDA Grants Accelerated Approval to Zanidatamab-hrii for Previously Treated Unresectable or Metastatic HER2-Positive Biliary Tract Cancer

Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC

Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System

Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma